The global mice model market size was USD 1.5 Billion in 2021, and expected to register a CAGR of 6.6%, during the forecast period. Market revenue growth is driven by key factor such as significant increase of biomedical research in most developed and developing countries over the last decade. Animal models, specifically mice models, usually receive a large portion of research investment.
Mice have been used as models of human biology and diseases, due to their phylogenetic and physiological similarities to humans, ease with which they can be maintained and bred in the laboratory, and existence of various inbred strains. The remarkable genetic similarities between the two species have been illustrated by genomic studies. These experiments, along with the development of methods for producing transgenic, knockout, and knocking mice, have given mice new impetus and powerful tools, resulting in a drastic increase in the use of mice as model organisms and the expansion of the mouse model market.
Request a Sample@ https://www.qyresearchmedical.com/sample/119145
Mice Model Market: Dynamics
Increasing biomedical research to drive market growth
The use of mice models has increased as a result of technological advances in gene editing, which has aided scientists in the development and production of novel drugs. These models are widely used in clinical studies in a variety of fields, including oncology and immunology. Demand for genetically modified humanized mice models has grown in response to growing need for personalized medicines.
The global mice model market is expected to be primarily driven by use of mice models in cancer research. This is of utmost importance as mice models aim to explore the casual link between candidate cancer genes and carcinogenesis as well as to provide models to develop and test new therapies. According to the American Cancer Society, there were approximately 1,688,780 new cancer cases diagnosed in the United States in 2017. In 2017, approximately 600,920 Americans were estimated to die of cancer, or about 1,650 people every day. Cancer is the second leading cause of death in the United States, accounting for almost one out of every four deaths. Furthermore, growing geriatric population in the United States is a major factor resulting in rising incidence of cancer across the country. For example, people of 50 years and older are diagnosed with 87% of total cancer patients in the United States.
The coronavirus epidemic that has resulted in the ongoing public health crisis. The need for vaccines and therapeutic agents to fight the current pandemic and avoid the re-emergence of COVID-19 is growing rapidly, resulting in need for mice models to test vaccines.
Enforcement of animal safety and welfare laws to restrain market growth
The enforcement of animal safety and welfare laws and regulations has led to stringent practices and prohibitions on use of animals for various purposes. Many countries have prohibited use of animals in the cosmetics industry in the last decade. Complying with required legislation for use of animal models can be time-consuming and inconvenient, and could restrain growth of the global mice model market.
Mice Type Outlook:
On the basis of mice type, the mice model market is segmented into inbred, outbred, knockout, hybrid, others. The inbred mice segment accounted for the largest share in 2020. The growth of the segment can be attributed to rising use of inbred mice in research of pharmacology and cardiovascular diseases, and to study responses of monoclonal antibodies. These type of mice are being considered as an important tool in genetics studies of complex diseases, owing to which there is high demand for inbred mice.
On the basis of technology, the mice model market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, others. In 2020, the microinjection segment accounted for the largest revenue share in the global mice model market. Revenue growth of this segment can be attributed to efficacy and flexibility features of the technique in producing genetically modified mice. The microinjection technique allows DNA to be injected into each cell of developing mice with a high potential for regeneration.
On the basis of use, the mice model market is segmented into human and veterinary. In 2020, the veterinary segment accounted for the largest revenue share, due to rising prevalence of several animal disorders such as seizures and severe infectious diseases, resulting in increasing R&D to develop veterinary medicines. Growing adoption of veterinary contract research organizations that offer mice models for veterinary drug discovery with related services, is expected to drive revenue growth of this segment. Additionally, research projects involving the use of mice models for veterinary research are well funded by National Institutes of Health (NIH), supporting growth of this segment.
On the basis of application, the global mice model market is segmented into research & development, infectious disease, immunological diseases, cancer, cardiovascular diseases, diabetes, genetic diseases, neurological diseases, others production and quality control, academics, and others. In 2021, the academics segment accounted for the largest revenue share, among the application segments, in the global mice model market, owing to increasing need for mice models in academic institutions. For pharmacology education, academic institutions use preserved mice models to understand drug toxicity behavior.
End Use Outlook:
On the basis of end use, the global mice model market is segmented into pharmaceutical, biotechnology, cosmetics, government, non-government, academic and research institutes, Contract Research Organizations (CRO), others. In 2021, the academic and research institutes segment accounted for the largest share in terms of revenue, owing to increasing use of mice models in academic institutions for studies purpose.
On the basis of region, the global mice model market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2021, the North America market accounted for the largest revenue share in the global mice model market, due to high prevalence of chronic diseases such as diabetes and viral diseases, and need for advanced novel drugs for treatment. The market in United States accounted for the largest revenue share in the North America mice model market, which was estimated at USD 6 Billion in 2021. Several research organizations in the country are focusing on production of innovative and enhanced therapeutic drugs for various diseases and disorders. In the United States, high-throughput mutagenesis projects are producing a significant number of mutant mouse models through the Knock Out Mouse Project (KOMP).
Europe mice model market accounted for the second largest revenue share followed by the Asia Pacific market. Mice models are widely used in the UK for vaccine research and development. Rising prevalence of Alzheimer\’s disease in the country is fuelling demand for research and development of drugs, thereby driving demand for mouse models for trials. The European Union funds research and development of mouse models for Alzheimer\’s disease through consortiums of research organizations.
The market in China offers lucrative growth opportunities for mice model players in the APAC region. Large population base and growing patient pool of chronic diseases necessitating comprehensive care for disease prevention, development in biological science due to large government funding, and well-established research laboratories in the country are factors driving the market in the country.
Some of the major players operating in the mice model market include genOway, Taconic Biosciences, Inc., Janvier Labs, Charles River, Envigo, and Hera BioLabs.
Segments Covered in the Report:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2022 to 2030. The global mice model market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global mice model market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
For the purpose of this report, has segmented the global mice model market on the basis of mice type, technology, use, application, end use and region:
Mice Model Market Report Scope
Segments covered By Mice Type Outlook, Technology Outlook, Use Outlook, Application Outlook, End Use Outlook,Regional Outlook
By Mice Type Outlook
By Technology Outlook
Embryonic Stem Cell Injection
By Use Outlook
By Application Outlook
Research & Development
Production and Quality Control
By End Use Outlook
Academic and Research Institutes
Contract Research Organizations (CRO)
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119145/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: